ArticleFrontiers in oncology2023

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.

Silvia Mihaela Ilie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.